As the most active isoenzyme in the HK family, the activation of HK2 drives tumor metabolism toward glycolysis in various malignant tumors, thereby regulating tumor progression and chemoresistance (Ciscato et al. 2021; Xie et al. 2023). The gene discussed is HK1; the disease is neoplasm.